BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ramachandra Pai RP, Kangath RV. Bilateral gangrene of fingers in a patient on empagliflozin: First case report. World J Diabetes 2019; 10(2): 133-136 [PMID: 30788049 DOI: 10.4239/wjd.v10.i2.133]
URL: https://www.wjgnet.com/1948-9358/full/v10/i2/133.htm
Number Citing Articles
1
Jyoti Yadav, Farogh Ahsan, Prabhudatta Panda, Tarique Mahmood, Vaseem Ahamad Ansari, Arshiya Shamim. Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview of its Chemistry, Pharmacology, and ToxicologyCurrent Diabetes Reviews 2024; 20(10) doi: 10.2174/0115733998271026231127051545
2
Mario Antunes, Antonio Cabrera de León, Damiano Pizzol, Amir Hussein Abubacar Seni, Mike Trott, Anne Marie Carrie, Petre-Cristian Ilie, Nicola Veronese, Lee Smith. Empagliflozin Use and Fournier’s Gangrene: Case Report and Systematic Literature ReviewSurgeries 2021; 2(2): 174 doi: 10.3390/surgeries2020018
3
Empagliflozin/prednisoneReactions Weekly 2019; 1748(1): 196 doi: 10.1007/s40278-019-60112-0
4
Mortaza F. Hassanabad, Zahra F.H. Abad. Are SGLT2 inhibitors joining the mainstream therapy for diabetes type 2?Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 1893 doi: 10.1016/j.dsx.2019.04.041